TAP1 gene polymorphisms and nasopharyngeal carcinoma risk in a Tunisian population

Elham Hassen, Karim Farhat, Sallouha Gabbouj, Majida Jalbout, Noureddine Bouaouina, Lotfi Chouchane

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

To find out whether polymorphisms 333-Ile/Val and 637-Asp/Gly of the transporter part of the antigen processing 1 gene (TAP1) are associated with the development of nasopharyngeal carcinoma (NPC), we studied a total of 374 subjects (209 patients and 165 controls). We used the amplification refractory mutation system polymerase chain reaction (ARMS-PCR) method for analyzing the TAP1 gene polymorphisms. We found a significant difference between the patients and the controls in both the TAP1 codon 333 and codon 637 (P = 0.009 and P = 0.002, respectively). We also found that genotypes with the A allele were present in 206 patients with NPC and 155 controls (98.5 vs. 93.9%; P = 0.032; OR = 4.43) and that genotypes with the B allele were more often present in the control group (45 vs. 32%; P = 0.004; OR = 0.48), suggesting a significant positive association of the A allele with NPC risk and a protective role of the B allele. We have observed an association between the distribution of TAP1 alleles and the NPC patient's age at onset, compared with controls. These results back up the fact that the etiology of NPC in intermediate-risk countries is completely different in each peak of age prevalence and that each peak may possess its own particular oncogenic mechanism.

Original languageEnglish
Pages (from-to)41-46
Number of pages6
JournalCancer Genetics and Cytogenetics
Volume175
Issue number1
DOIs
Publication statusPublished - May 2007
Externally publishedYes

Fingerprint

Antigen Presentation
Alleles
Population
Genes
Codon
Genotype
Age of Onset
Nasopharyngeal carcinoma
Polymerase Chain Reaction
Control Groups
Mutation

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

TAP1 gene polymorphisms and nasopharyngeal carcinoma risk in a Tunisian population. / Hassen, Elham; Farhat, Karim; Gabbouj, Sallouha; Jalbout, Majida; Bouaouina, Noureddine; Chouchane, Lotfi.

In: Cancer Genetics and Cytogenetics, Vol. 175, No. 1, 05.2007, p. 41-46.

Research output: Contribution to journalArticle

Hassen, Elham ; Farhat, Karim ; Gabbouj, Sallouha ; Jalbout, Majida ; Bouaouina, Noureddine ; Chouchane, Lotfi. / TAP1 gene polymorphisms and nasopharyngeal carcinoma risk in a Tunisian population. In: Cancer Genetics and Cytogenetics. 2007 ; Vol. 175, No. 1. pp. 41-46.
@article{941b2bb1b1904414b2d1d72359c51c84,
title = "TAP1 gene polymorphisms and nasopharyngeal carcinoma risk in a Tunisian population",
abstract = "To find out whether polymorphisms 333-Ile/Val and 637-Asp/Gly of the transporter part of the antigen processing 1 gene (TAP1) are associated with the development of nasopharyngeal carcinoma (NPC), we studied a total of 374 subjects (209 patients and 165 controls). We used the amplification refractory mutation system polymerase chain reaction (ARMS-PCR) method for analyzing the TAP1 gene polymorphisms. We found a significant difference between the patients and the controls in both the TAP1 codon 333 and codon 637 (P = 0.009 and P = 0.002, respectively). We also found that genotypes with the A allele were present in 206 patients with NPC and 155 controls (98.5 vs. 93.9{\%}; P = 0.032; OR = 4.43) and that genotypes with the B allele were more often present in the control group (45 vs. 32{\%}; P = 0.004; OR = 0.48), suggesting a significant positive association of the A allele with NPC risk and a protective role of the B allele. We have observed an association between the distribution of TAP1 alleles and the NPC patient's age at onset, compared with controls. These results back up the fact that the etiology of NPC in intermediate-risk countries is completely different in each peak of age prevalence and that each peak may possess its own particular oncogenic mechanism.",
author = "Elham Hassen and Karim Farhat and Sallouha Gabbouj and Majida Jalbout and Noureddine Bouaouina and Lotfi Chouchane",
year = "2007",
month = "5",
doi = "10.1016/j.cancergencyto.2007.01.009",
language = "English",
volume = "175",
pages = "41--46",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - TAP1 gene polymorphisms and nasopharyngeal carcinoma risk in a Tunisian population

AU - Hassen, Elham

AU - Farhat, Karim

AU - Gabbouj, Sallouha

AU - Jalbout, Majida

AU - Bouaouina, Noureddine

AU - Chouchane, Lotfi

PY - 2007/5

Y1 - 2007/5

N2 - To find out whether polymorphisms 333-Ile/Val and 637-Asp/Gly of the transporter part of the antigen processing 1 gene (TAP1) are associated with the development of nasopharyngeal carcinoma (NPC), we studied a total of 374 subjects (209 patients and 165 controls). We used the amplification refractory mutation system polymerase chain reaction (ARMS-PCR) method for analyzing the TAP1 gene polymorphisms. We found a significant difference between the patients and the controls in both the TAP1 codon 333 and codon 637 (P = 0.009 and P = 0.002, respectively). We also found that genotypes with the A allele were present in 206 patients with NPC and 155 controls (98.5 vs. 93.9%; P = 0.032; OR = 4.43) and that genotypes with the B allele were more often present in the control group (45 vs. 32%; P = 0.004; OR = 0.48), suggesting a significant positive association of the A allele with NPC risk and a protective role of the B allele. We have observed an association between the distribution of TAP1 alleles and the NPC patient's age at onset, compared with controls. These results back up the fact that the etiology of NPC in intermediate-risk countries is completely different in each peak of age prevalence and that each peak may possess its own particular oncogenic mechanism.

AB - To find out whether polymorphisms 333-Ile/Val and 637-Asp/Gly of the transporter part of the antigen processing 1 gene (TAP1) are associated with the development of nasopharyngeal carcinoma (NPC), we studied a total of 374 subjects (209 patients and 165 controls). We used the amplification refractory mutation system polymerase chain reaction (ARMS-PCR) method for analyzing the TAP1 gene polymorphisms. We found a significant difference between the patients and the controls in both the TAP1 codon 333 and codon 637 (P = 0.009 and P = 0.002, respectively). We also found that genotypes with the A allele were present in 206 patients with NPC and 155 controls (98.5 vs. 93.9%; P = 0.032; OR = 4.43) and that genotypes with the B allele were more often present in the control group (45 vs. 32%; P = 0.004; OR = 0.48), suggesting a significant positive association of the A allele with NPC risk and a protective role of the B allele. We have observed an association between the distribution of TAP1 alleles and the NPC patient's age at onset, compared with controls. These results back up the fact that the etiology of NPC in intermediate-risk countries is completely different in each peak of age prevalence and that each peak may possess its own particular oncogenic mechanism.

UR - http://www.scopus.com/inward/record.url?scp=34247897130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247897130&partnerID=8YFLogxK

U2 - 10.1016/j.cancergencyto.2007.01.009

DO - 10.1016/j.cancergencyto.2007.01.009

M3 - Article

VL - 175

SP - 41

EP - 46

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 1

ER -